Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Carafate

02 2Carafate/Sulcrate

03 1Carafate?/Sulcrate?

PharmaCompass

01

Brand Name : Carafate

arrow
Antibody Engineering
Not Confirmed

Sucralfate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 239

2016 Revenue in Millions : 231

Growth (%) : 3

Abbvie CB

02

Brand Name : Carafate/Sulcrate

arrow
Antibody Engineering
Not Confirmed

Sucralfate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 221

2017 Revenue in Millions : 239

Growth (%) : -8%

Abbvie CB

03

Brand Name : Carafate/Sulcrate

arrow
Antibody Engineering
Not Confirmed

Sucralfate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 231

2015 Revenue in Millions : 213

Growth (%) : 8

Abbvie CB

04

Brand Name : Carafate?/Sulcrate?

arrow
Antibody Engineering
Not Confirmed

Sucralfate

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 216

2018 Revenue in Millions : 221

Growth (%) : -2

Abbvie CB

05

Brand Name : Carafate

Sucralfate

arrow
Antibody Engineering
Not Confirmed

Brand Name : Carafate

arrow
Antibody Engineering
Not Confirmed

Sucralfate

Main Therapeutic Indication : Gastrointestinal disorders

Currency : USD

2014 Revenue in Millions :

2013 Revenue in Millions :

Growth (%) :

blank